Reduced heart rate variability predicts incident diabetic polyneuropathy - Report - MDSpire

Reduced heart rate variability predicts incident diabetic polyneuropathy

  • By

  • Dimitrios Tsilingiris

  • Daniel Schmalzridt

  • Omar Eldesouky

  • Florian Kalb

  • Viktoria Flegka

  • Ekaterina von Rauchhaupt

  • Theresa Hoefer

  • Stefan Kopf

  • Thomas Fleming

  • Stephan Herzig

  • Anna Hohneck

  • Julia Szendroedi

  • Zoltan Kender

  • July 16, 2026

Share

Clinical Report: Decreased heart rate variability as a predictor of new-onset diabetic polyneuropathy

Overview

This study investigates the predictive value of cardiovascular autonomic neuropathy (CAN) and reduced heart rate variability (HRV) for the development of distal symmetrical polyneuropathy (DSPN) in individuals with diabetes mellitus. Findings indicate that established CAN is a predictor of future DSPN, while reduced HRV serves as a marker for identifying individuals at risk.

Background

Distal symmetrical polyneuropathy (DSPN) is a prevalent microvascular complication in diabetes, significantly impacting patient mobility and quality of life. Early identification of individuals at high risk for DSPN is crucial, as no specific therapy exists to reverse the condition. Cardiovascular autonomic neuropathy (CAN) is associated with adverse outcomes in diabetes, and understanding its relationship with DSPN may enhance risk stratification.

Data Highlights

MeasureValue
CAN prevalence16.3%
Low HRV indices prevalence18.6–40.2%
DSPN prevalence (definition i)27.7%
Incident DSPN rate8.4 per 100 person-years

Key Findings

  • CAN prevalence was found to be 16.3% among participants.
  • Low HRV indices were present in 18.6–40.2% of individuals with diabetes.
  • DSPN prevalence varied based on definitions: 27.7% (clinical criteria), 17.6% (sensory-loss phenotype), and 20.8% (Toronto consensus definition).
  • Baseline CAN independently predicted incident DSPN with adjusted hazard ratios ranging from 3.30 to 7.33.
  • Lower rMSSD, HF power, and LF power were predictive of incident DSPN according to specific definitions.

Clinical Implications

The findings indicate the importance of assessing CAN and HRV in individuals with diabetes to identify those at risk for developing DSPN.

Conclusion

The study establishes that CAN is a predictor of future DSPN, while reduced HRV serves as a marker for risk identification in diabetes management.

Related Resources & Content

  1. Frontiers in Endocrinology, 2026 -- Dapagliflozin associates with heart rate variability decline in T2DM patients on GLP-1 receptor agonist therapy: a prospective observational study
  2. European Journal of Preventive Cardiology, 2026 -- Circadian Variations in Heart Rate as Predictors of Cardiovascular and Overall Mortality in Type 1 and Type 2 Diabetes: Findings from a 21-Year Longitudinal Study
  3. Frontiers in Endocrinology, 2026 -- Development and validation of a nomogram model for predicting cardiac autonomic neuropathy in patients with diabetes
  4. European Journal of Preventive Cardiology, 2026 -- The added value of electrocardiogram abnormalities in predicting incident cardiovascular disease risk for people with Type 2 diabetes: the Hoorn Diabetes Care System cohort
  5. Retinopathy, Neuropathy, and Foot Care: Standards of Care in Diabetes—2026 - PMC
  6. Diabetic Neuropathy: A Position Statement by the American Diabetes Association | Diabetes Care | American Diabetes Association
  7. Predictors of incident diabetic peripheral neuropathy: a systematic review of longitudinal studies in patients with diabetes mellitus - PubMed
  8. 12. Retinopathy, Neuropathy, and Foot Care: Standards of Care in Diabetes—2026 - PMC
  9. Diabetic Neuropathy: A Position Statement by the American Diabetes Association | Diabetes Care | American Diabetes Association
  10. Predictors of incident diabetic peripheral neuropathy: a systematic review of longitudinal studies in patients with diabetes mellitus - PubMed

Original Source(s)

Related Content